Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Sales: 2010-2024

Historic Return on Sales for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -1.05%.

  • China Pharma Holdings' Return on Sales rose 7.00% to -0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.79%, marking a year-over-year increase of 7.00%. This contributed to the annual value of -1.05% for FY2024, which is 61.00% down from last year.
  • China Pharma Holdings' Return on Sales amounted to -1.05% in FY2024, which was down 138.16% from -0.44% recorded in FY2023.
  • Over the past 5 years, China Pharma Holdings' Return on Sales peaked at -0.26% during FY2020, and registered a low of -1.05% during FY2024.
  • In the last 3 years, China Pharma Holdings' Return on Sales had a median value of -0.49% in 2022 and averaged -0.66%.
  • In the last 5 years, China Pharma Holdings' Return on Sales surged by 163bps in 2020 and then slumped by 61bps in 2024.
  • Over the past 5 years, China Pharma Holdings' Return on Sales (Yearly) stood at -0.26% in 2020, then declined by 9bps to -0.35% in 2021, then fell by 14bps to -0.49% in 2022, then climbed by 5bps to -0.44% in 2023, then crashed by 61bps to -1.05% in 2024.